CLINICAL_TRIALS
research
· 2012-05-07
Clinical Trial Update: F18-FLT PET/CT as a Tool for Assessment of Myeloablative Treatment in Patients With Acute Myeloid Leucemia(AML)
Summary
This entry reports on a clinical trial evaluating F18-FLT PET/CT as a tool to assess the effectiveness of myeloablative treatment in patients with acute myeloid…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hadassah Medical Organization | Conditions: Acute Myeloid Leucemia | Status: UNKNOWN